Clinical trials
Diabetes Mellitus trials in Indonesia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
45 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 4 |
| 2009 | 2 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 4 |
| 2021 | 2 |
| 2022 | 3 |
| 2024 | 2 |
| 2025 | 7 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 28 |
| Unknown status | 7 |
| Not yet recruiting | 6 |
| Active, not recruiting | 2 |
| Terminated | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novo Nordisk A/S | 10 |
| Indonesia University | 6 |
| Tarumanagara University | 4 |
| Dexa Medica Group | 3 |
| Hasanuddin University | 3 |
| Andalas University | 2 |
| Taipei Medical University | 2 |
| Universitas Padjadjaran | 2 |
| Universitas Sebelas Maret | 2 |
| Bayer | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus | 45 |
| Diabetes Mellitus, Type 2 | 18 |
| Dyslipidemias | 5 |
| Insulin Resistance | 5 |
| Diabetes Mellitus, Type 1 | 4 |
| Diabetic Foot | 4 |
| Diabetic Neuropathies | 4 |
| Obesity | 4 |
| Hypertension | 3 |
| Diabetes Complications | 2 |
Trials
Showing 51 to 45 of 45. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.